ArticleRSC advances2025

Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors.

Sudhakar Tangallapalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.